busulfan, melphalan, and fludarabine regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for busulfan, melphalan, and fludarabine regimen, covering 2021-09-24 to 2021-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]